| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/09/2014 | CN102462846B 一种氯代毒素修饰的脑胶质瘤靶向基因递释复合物及其制备方法 One kind of modified chlorinated toxins targeted gene delivery glioma release compound and preparation method |
| 07/09/2014 | CN102309448B 一种肺部给药的环丙沙星药用组合物及其制备方法 Ciprofloxacin pharmaceutical composition and preparation method of pulmonary administration |
| 07/09/2014 | CN102266302B 旨在避免非主观误服和非法滥服的抗张性片剂 Designed to avoid the reach of non-subjective and illegal Lanfu tensile tablets |
| 07/09/2014 | CN102233129B 一种预防或治疗视网膜损伤的长效缓释制剂及其制备方法 A method of preventing or treating retinal damage long-acting release formulation and preparation method |
| 07/09/2014 | CN102188378B 包载水溶性药物脂质体的制备方法 Preparation of a water-soluble drug entrapped in liposomes |
| 07/09/2014 | CN101653603B 磷脂酰乙醇胺结合肽缀合物及其治疗病毒感染的用途 Phosphatidylethanolamine binding peptide conjugates and their use to treat viral infections |
| 07/09/2014 | CN101627974B 一日服用一次的羟考酮制剂 Taken once a day formulation of oxycodone |
| 07/09/2014 | CN101355953B 麻醉苏醒促进剂 Anesthesia accelerator |
| 07/08/2014 | US8772472 SiRNA conjugate and preparation method thereof |
| 07/08/2014 | US8772451 Soluble TCR molecules and methods of use |
| 07/08/2014 | US8772355 Stealth polymeric particles for delivery of bioactive or diagnostic agents |
| 07/08/2014 | US8772341 Compositions for the treatment of hoof diseases |
| 07/08/2014 | US8772270 Treatment methods requiring phyto-ingredients |
| 07/08/2014 | US8772255 Cell transfecting formulations of small interfering RNA related compositions and methods of making and use |
| 07/08/2014 | US8772248 Drug delivery system |
| 07/08/2014 | US8772246 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/08/2014 | US8772235 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 07/08/2014 | US8772227 Glucosamine pro-drug |
| 07/08/2014 | US8772013 Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 07/08/2014 | US8771764 Composition and method for improving vascular health |
| 07/08/2014 | US8771757 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 07/08/2014 | US8771750 Delivery or removal of metals from biological systems |
| 07/08/2014 | US8771739 Pharmaceutical compositions for poorly soluble drugs |
| 07/08/2014 | US8771734 Sustained-release hydrogel preparation |
| 07/08/2014 | US8771726 Nail patch |
| 07/08/2014 | US8771720 Medical device comprising polyhydroxyalkanoate having pyrogen removed using oxidizing agent |
| 07/08/2014 | US8771659 Cosmetic compositions comprising at least one starch and at least one peg fatty diester, and uses thereof |
| 07/08/2014 | US8771650 Inducible release vehicles |
| 07/08/2014 | US8771649 Inducible release vehicles |
| 07/08/2014 | CA2784240C Stable bortezomib formulations |
| 07/08/2014 | CA2745904C Sparc binding peptides and uses thereof |
| 07/08/2014 | CA2685269C Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 07/08/2014 | CA2672024C Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use |
| 07/08/2014 | CA2652759C Nanoparticles for providing immune responses against infectious agents |
| 07/08/2014 | CA2652220C Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 07/08/2014 | CA2617188C Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
| 07/08/2014 | CA2595063C Emulsified composition for dilution and cancer vaccine composition |
| 07/08/2014 | CA2566874C Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |
| 07/08/2014 | CA2565182C Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer |
| 07/08/2014 | CA2547165C Mutated anti-cd22 antibodies and immunoconjugates |
| 07/08/2014 | CA2524891C Ultraviolet-shielding type patch |
| 07/08/2014 | CA2497195C Methods and compositions for controlled release of drugs |
| 07/08/2014 | CA2492490C Chinese herbal medical composition in the form of jelly |
| 07/08/2014 | CA2482448C Preservation of bioactive materials by freeze dried foam |
| 07/08/2014 | CA2350890C Aqueous compositions for long-term stable storage of adenovirus particles including uses and methods for preparing same |
| 07/08/2014 | CA2333087C Compositions and methods for the pulmonary delivery of nucleic acids |
| 07/03/2014 | WO2014106208A1 Targeted conjugates encapsulated in particles and formulations thereof |
| 07/03/2014 | WO2014106160A1 Metal particle mri contrast agents and methods of use |
| 07/03/2014 | WO2014106116A2 Delivery of biologic therapeutics |
| 07/03/2014 | WO2014105822A1 Administration of recombinant collagen 7 for the treatment of age related disorders |
| 07/03/2014 | WO2014104981A1 Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications |
| 07/03/2014 | WO2014104929A1 Pharmaceutical composition for treatment of hiv infections |
| 07/03/2014 | WO2014104868A1 Detoxifying, antimicrobial molecular complex |
| 07/03/2014 | WO2014104844A1 Microgranular formulation including coagulation unit comprising discontinuous phase and continuous phase |
| 07/03/2014 | WO2014104840A1 Novel microgranular formulation |
| 07/03/2014 | WO2014104822A1 Method for producing microspheres using methyl propionate |
| 07/03/2014 | WO2014104791A1 Sustained-release lipid pre-concentrate of gnrh analogues and pharmaceutical composition comprising the same |
| 07/03/2014 | WO2014104788A1 Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same |
| 07/03/2014 | WO2014104784A1 Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the same |
| 07/03/2014 | WO2014104671A1 Pharmaceutical composition with improved stability, containing temozolomide, and preparation method therefor |
| 07/03/2014 | WO2014104670A1 Melt extruded pharmaceutical composition for controlling release, and medicine for oral administration including same |
| 07/03/2014 | WO2014104316A1 Sphingomyelin-containing supplement |
| 07/03/2014 | WO2014104255A1 High-purity monoalkenyl-containing glycerin derivative, and method for producing same |
| 07/03/2014 | WO2014104230A1 Dialysis agent, and method for producing dialysis agent |
| 07/03/2014 | WO2014104227A1 Peptides for transferring target molecules into cells |
| 07/03/2014 | WO2014104220A1 Packaging |
| 07/03/2014 | WO2014104149A1 Preparation for application to skin |
| 07/03/2014 | WO2014103987A1 Dispersion stabilizer for particulate substance and dispersion stabilization method therefor |
| 07/03/2014 | WO2014103737A1 Water-based carbonated beverage |
| 07/03/2014 | WO2014103488A1 Nasal influenza vaccine composition |
| 07/03/2014 | WO2014103410A1 Igf-1 production promoter |
| 07/03/2014 | WO2014102824A1 Diclofenac composition |
| 07/03/2014 | WO2014102755A1 Bortezomib formulations |
| 07/03/2014 | WO2014102679A1 Novel veterinary pharmaceutical compositions and method for the production thereof |
| 07/03/2014 | WO2014102623A1 Pharmaceutical composition |
| 07/03/2014 | WO2014102539A1 Delivery method using mesoporous silica nanoparticles |
| 07/03/2014 | WO2014102498A1 Dermatological composition comprising a pde7 inhibitor in a dispersed form, method for the production thereof, and use of same |
| 07/03/2014 | WO2014102497A1 Dermatological composition comprising a pde7 inhibitor in a solubilised form, production method thereof, and use of same |
| 07/03/2014 | WO2014102265A1 Methods and compositions relating to crm197 |
| 07/03/2014 | WO2014102253A1 Monolithic dosage form for the modified release of an active ingredient combination |
| 07/03/2014 | WO2014102090A1 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease |
| 07/03/2014 | WO2014101986A1 Dry granulation process for producing tablet compositions of metformin and compositions thereof |
| 07/03/2014 | WO2014101743A1 Freeze-dried excipient and preparation method thereof |
| 07/03/2014 | WO2014101356A1 Gamabufotalin liposome, preparation method therefor and applicationthereof |
| 07/03/2014 | WO2014101115A1 Montelukast sodium tablet composition and preparation method thereof |
| 07/03/2014 | WO2014101038A1 Method for preparing drug-loaded microspheres |
| 07/03/2014 | WO2014075593A9 Mesenchymal stem cell injection, preparation method thereof, and application thereof in preparing drug for treating ulcerative colitis |
| 07/03/2014 | WO2014072411A9 C4s proteoglycan specific transporter molecules |
| 07/03/2014 | WO2013189800A9 Cisatracurium and beta-cyclodextrin derivative compositions |
| 07/03/2014 | WO2013135359A8 Targeting aminoacid lipids |
| 07/03/2014 | US20140188056 Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents |
| 07/03/2014 | US20140187790 Oligomer-opioid agonist conjugates |
| 07/03/2014 | US20140187756 Methods of preparing antibody-active agent conjugates |
| 07/03/2014 | US20140187650 Method for easing human childbirth using a lubricant composition |
| 07/03/2014 | US20140187635 Diclofenac compositions |
| 07/03/2014 | US20140187629 Use of Bethanechol for Treatment of Xerostomia |
| 07/03/2014 | US20140187628 Palatable suspending vehicle for pharmaceutical ingredients |
| 07/03/2014 | US20140187582 Solid dispersions of amorphous paroxetine mesylate |
| 07/03/2014 | US20140187578 Pharmaceutical Topical Compositions |
| 07/03/2014 | US20140187520 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof |